- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/54 - Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 213/54
Total number of patents in this class: 59
10-year publication summary
|
2
|
1
|
7
|
6
|
5
|
6
|
6
|
2
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Fortephest Ltd. | 12 |
5 |
| Shenzhen Chipscreen Biosciences Ltd. | 25 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 847 |
3 |
| Toyama Chemical Co., Ltd. | 88 |
3 |
| Calico Life Sciences LLC | 118 |
3 |
| VALO Health, Inc. | 195 |
3 |
| The Regents of the University of California | 20842 |
2 |
| Genentech, Inc. | 4119 |
2 |
| Bayer Pharma AG | 1009 |
2 |
| Abbvie Inc. | 1799 |
2 |
| Epizyme, Inc. | 360 |
2 |
| Nippon Shinyaku Co., Ltd. | 325 |
2 |
| Samjin Pharmaceutical Co., Ltd. | 49 |
2 |
| Glaxo Group Limited | 4370 |
1 |
| Boehringer Ingelheim International GmbH | 4485 |
1 |
| Syngenta Crop Protection AG | 6738 |
1 |
| Syngenta Limited | 424 |
1 |
| DSM IP Assets B.V. | 5390 |
1 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2313 |
1 |
| CHDI Foundation, Inc. | 107 |
1 |
| Other owners | 18 |